- Home
- HYI vs HRTX Comparison
HYI vs HRTX Comparison
Compare HYI & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HYI
- HRTX
- Stock Information
- Founded
- HYI 2010
- HRTX 1983
- Country
- HYI United States
- HRTX United States
- Employees
- HYI N/A
- HRTX N/A
- Industry
- HYI Investment Managers
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- HYI Finance
- HRTX Health Care
- Exchange
- HYI Nasdaq
- HRTX Nasdaq
- Market Cap
- HYI 266.3M
- HRTX 270.7M
- IPO Year
- HYI N/A
- HRTX 1987
- Fundamental
- Price
- HYI $12.05
- HRTX $1.73
- Analyst Decision
- HYI
- HRTX Strong Buy
- Analyst Count
- HYI 0
- HRTX 3
- Target Price
- HYI N/A
- HRTX $5.67
- AVG Volume (30 Days)
- HYI 50.6K
- HRTX 1.2M
- Earning Date
- HYI 01-01-0001
- HRTX 02-27-2025
- Dividend Yield
- HYI 9.59%
- HRTX N/A
- EPS Growth
- HYI N/A
- HRTX N/A
- EPS
- HYI N/A
- HRTX N/A
- Revenue
- HYI N/A
- HRTX $137,737,000.00
- Revenue This Year
- HYI N/A
- HRTX $13.10
- Revenue Next Year
- HYI N/A
- HRTX $14.03
- P/E Ratio
- HYI N/A
- HRTX N/A
- Revenue Growth
- HYI N/A
- HRTX 12.13
- 52 Week Low
- HYI $10.99
- HRTX $1.04
- 52 Week High
- HYI $12.24
- HRTX $3.93
- Technical
- Relative Strength Index (RSI)
- HYI 47.47
- HRTX 52.86
- Support Level
- HYI $12.12
- HRTX $1.63
- Resistance Level
- HYI $12.21
- HRTX $1.83
- Average True Range (ATR)
- HYI 0.10
- HRTX 0.10
- MACD
- HYI -0.00
- HRTX -0.01
- Stochastic Oscillator
- HYI 34.62
- HRTX 41.94
About HYI Western Asset High Yield Defined Opportunity Fund Inc.
Western Asset High Yield Defined Opps. is a non-diversified, limited-term, closed-end management investment company. The company's investment objective is to provide high income and seek capital appreciation. It invests a majority of its net assets in a portfolio of high-yield corporate fixed-income securities issued or originated by U.S. or foreign public or private corporations and other business entities, with varying maturities.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.